C12N 2710/16044
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2710/16044 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 2 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 4
- Assignees
- 2
- Inventors
- 7
- Latest grant
- 4 Jul 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Adeno-associated virus Factor VIII vectors, associated viral particles and therapeutic formulations comprising the same4 Jul 2023US 11,690,898 B2Biomarin Pharmaceutical Inc.
- Adeno-associated virus factor VIII vectors, associated viral particles and therapeutic formulations comprising the same24 Dec 2019US 10,512,675 B2Biomarin Pharmaceutical Inc.
- Adeno-Associated Virus Production Platform9 Jul 2026US 2026/0193676 A1MedImmune, LLC
- Adeno-Associated Virus Factor VIII Vectors, Associated Viral Particles and Therapeutic Formulations Comprising the Same22 Feb 2024US 2024/0058423 A1Biomarin Pharmaceutical Inc.
- Adeno-associated virus factor viii vectors, associated viral particles and therapeutic formulations comprising the same27 Feb 2020US 2020/0061161 A1Biomarin Pharmaceutical Inc.
- Adeno-Associated Virus Factor VIII Vectors, Associated Viral Particles and Therapeutic Formulations Comprising the Same30 Mar 2017US 2017/0087219 A1Biomarin Pharmaceutical Inc.
Most cited
By later US patents